Abiopharma

Edmonds Ronald C 🟡 adjusted position in 195.9K shares (1 derivative) of NOVONIX Ltd (NVX) Transaction Date: May 06, 2026 | Filing ID: 207584

General Announcement: Announcements by GuocoLand Limiteds associate, Tower Real Estate Investment Trust ("Tower REIT")

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001839882-26-023129 <b>Size:</b> 734 KB

Burrow Sharan 🟡 adjusted position in 195.9K shares (1 derivative) of NOVONIX Ltd (NVX) Transaction Date: May 06, 2026 | Filing ID: 207579

Zimmer Biomet Holdings, Inc. Notification

(80% Positive) ASP ISOTOPES INC. (ASPI) Announces Business Combination

Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics

Barmonde Charles L. 🟡 adjusted position in 90.7K shares (2 derivative) of E.W. SCRIPPS Co (SSP) Transaction Date: May 04, 2026 | Filing ID: 000002

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Changes in Interest of Director - Chua Beng Yong

(90% Positive) ROYALTY PHARMA PLC (RPRX) Announces Business Combination

(99% Positive) HNI CORP (HNI) Reports Q2 2026 Financial Results

(35% Negative) ON SEMICONDUCTOR CORP (ON) Announces Business Combination

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001213900-26-052611 <b>Size:</b> 477 KB

BriaCell Receives FDA Clearance to InitiateBria-BRES+™ Clinical Study in Breast Cancer

908 Devices Inc. - 908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook